-
lung fibrosis. The ideal candidate will independently perform studies utilizing established in vitro, ex vivo and in vivo preclinical models and will have the opportunity to develop and refine novel
-
. * Examine mechanisms of organ cross-talk between the heart, vasculature, and brain. * Utilize in vitro and in vivo models, including inflammatory and aging-related models. * Perform molecular
-
dysfunction in heart failure, sepsis, and related inflammatory conditions. Utilize in vitro and in vivo models, including mouse models of sepsis (e.g., CLP, LPS), ischemiareperfusion injury, and vascular injury
-
biological applications. You will design and implement models ranging from molecular to process scales, develop model-predictive control and optimization strategies, run high-performance numerical experiments
-
of scientific mentor Dr. Liping Yang (https://medicine.osu.edu/find-faculty/non-clinical/molecular-medicine-and-therapeutics/liping-yang ) at the Comprehensive Cancer Center at the Ohio State University. Post